Page last updated: 2024-09-02

ecteinascidin 743 and sdz psc 833

ecteinascidin 743 has been researched along with sdz psc 833 in 3 studies

Compound Research Comparison

Studies
(ecteinascidin 743)
Trials
(ecteinascidin 743)
Recent Studies (post-2010)
(ecteinascidin 743)
Studies
(sdz psc 833)
Trials
(sdz psc 833)
Recent Studies (post-2010) (sdz psc 833)
6601024044555566

Protein Interaction Comparison

ProteinTaxonomyecteinascidin 743 (IC50)sdz psc 833 (IC50)
ATP-dependent translocase ABCB1Homo sapiens (human)0.3969

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Astolfi, A; Bagnati, R; Benini, S; D'Incalci, M; Hattinger, CM; Manara, MC; Perdichizzi, S; Picci, P; Pierini, R; Scotlandi, K; Serra, M1

Other Studies

3 other study(ies) available for ecteinascidin 743 and sdz psc 833

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
The molecular mechanisms responsible for resistance to ET-743 (Trabectidin; Yondelis) in the Ewing's sarcoma cell line, TC-71.
    International journal of oncology, 2005, Volume: 27, Issue:6

    Topics: Antineoplastic Agents, Alkylating; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cell Proliferation; Cyclosporins; Dioxoles; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Fluorescent Antibody Technique, Indirect; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genome, Human; Humans; Inhibitory Concentration 50; Isoquinolines; Nucleic Acid Hybridization; Oligonucleotide Array Sequence Analysis; Receptor, IGF Type 1; Sarcoma, Ewing; Tetrahydroisoquinolines; Time Factors; Trabectedin

2005